CarsonAllaria Wealth Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-565
Closed -$5.61K 151
2025
Q2
$5.61K Hold
565
﹤0.01% 280
2025
Q1
$7.33K Hold
565
﹤0.01% 270
2024
Q4
$7.21K Hold
565
﹤0.01% 267
2024
Q3
$6.29K Hold
565
﹤0.01% 292
2024
Q2
$6.34K Hold
565
﹤0.01% 280
2024
Q1
$7.01K Hold
565
﹤0.01% 270
2023
Q4
$7.9K Hold
565
0.01% 229
2023
Q3
$8.35K Hold
565
0.01% 223
2023
Q2
$7.3K Hold
565
0.01% 242
2023
Q1
$5.54K Hold
565
﹤0.01% 254
2022
Q4
$6K Hold
565
0.01% 224
2022
Q3
$6K Hold
565
0.01% 216
2022
Q2
$7K Buy
565
+150
+36% +$1.59K 0.01% 208
2022
Q1
$4K Hold
415
﹤0.01% 262
2021
Q4
$6K Buy
+415
New +$6.83K 0.01% 250

Other funds holding DVAX

CarsonAllaria Wealth Management's DVAX Position: Q3 2025 in Review

CarsonAllaria Wealth Management sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 565 shares — an estimated $5.61K sold.

CarsonAllaria Wealth Management first reported a position in DVAX in Q4 2021 and held it in 15 quarters. The position peaked at $8.35K in Q3 2023. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • CarsonAllaria Wealth Management reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 565 Dynavax Technologies shares in Q3 2025, an estimated $5.61K.
  • CarsonAllaria Wealth Management first reported a position in Dynavax Technologies in Q4 2021 and held it in 15 quarters.
  • CarsonAllaria Wealth Management's Dynavax Technologies position peaked at $8.35K in Q3 2023.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.